The release of high mobility group protein B1 (HMGB1) was demonstrated to drive IL-10 production in TAMs selectively through the receptor for advanced glycation end products (RAGE), leading to an IL-10-rich milieu within the tumor (111). Here, HMGB1 is linked to neoplasm.